These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

663 related items for PubMed ID: 22202498

  • 1. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
    Fieland D, Taylor M.
    Ann Pharmacother; 2012 Jan; 46(1):e3. PubMed ID: 22202498
    [Abstract] [Full Text] [Related]

  • 2. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
    Brunetti L, Chen C, White J.
    Consult Pharm; 2014 Mar; 29(3):169-78. PubMed ID: 24589766
    [Abstract] [Full Text] [Related]

  • 3. [Direct oral thrombin inhibitor, "dabigatran"].
    Yasaka M.
    Nihon Rinsho; 2013 Jan; 71(1):113-8. PubMed ID: 23631181
    [Abstract] [Full Text] [Related]

  • 4. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
    Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, Yang S, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J, Yusuf S.
    Circulation; 2011 May 31; 123(21):2363-72. PubMed ID: 21576658
    [Abstract] [Full Text] [Related]

  • 5. Twice daily dosing of dabigatran for stroke prevention in atrial fibrillation: a pharmacokinetic justification.
    Clemens A, Haertter S, Friedman J, Brueckmann M, Stangier J, van Ryn J, Lehr T.
    Curr Med Res Opin; 2012 Feb 31; 28(2):195-201. PubMed ID: 22208675
    [Abstract] [Full Text] [Related]

  • 6. Drug-induced exanthem following dabigatran.
    Whitehead H, Boyd JM, Blais DM, Hummel J.
    Ann Pharmacother; 2011 Oct 31; 45(10):e53. PubMed ID: 21881034
    [Abstract] [Full Text] [Related]

  • 7. Modeling of the impact on health outcomes of the use of dabigatran in patients with atrial fibrillation.
    Chevalier J, Giroud M, de Pouvourville G.
    Cerebrovasc Dis; 2013 Oct 31; 35(4):320-6. PubMed ID: 23615428
    [Abstract] [Full Text] [Related]

  • 8. Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.
    Hohnloser SH, Oldgren J, Yang S, Wallentin L, Ezekowitz M, Reilly P, Eikelboom J, Brueckmann M, Yusuf S, Connolly SJ.
    Circulation; 2012 Feb 07; 125(5):669-76. PubMed ID: 22215856
    [Abstract] [Full Text] [Related]

  • 9. Dental management considerations for a patient taking dabigatran etexilate: a case report.
    Romond KK, Miller CS, Henry RG.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep 07; 116(3):e191-5. PubMed ID: 23850368
    [Abstract] [Full Text] [Related]

  • 10. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, Rao Y, Walker D, Sander S, Miyasato G, Matchar D, Sanchez H.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):567-74. PubMed ID: 23922182
    [Abstract] [Full Text] [Related]

  • 11. The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.
    Connolly SJ, Wallentin L, Ezekowitz MD, Eikelboom J, Oldgren J, Reilly PA, Brueckmann M, Pogue J, Alings M, Amerena JV, Avezum A, Baumgartner I, Budaj AJ, Chen JH, Dans AL, Darius H, Di Pasquale G, Ferreira J, Flaker GC, Flather MD, Franzosi MG, Golitsyn SP, Halon DA, Heidbuchel H, Hohnloser SH, Huber K, Jansky P, Kamensky G, Keltai M, Kim SS, Lau CP, Le Heuzey JY, Lewis BS, Liu L, Nanas J, Omar R, Pais P, Pedersen KE, Piegas LS, Raev D, Smith PJ, Talajic M, Tan RS, Tanomsup S, Toivonen L, Vinereanu D, Xavier D, Zhu J, Wang SQ, Duffy CO, Themeles E, Yusuf S.
    Circulation; 2013 Jul 16; 128(3):237-43. PubMed ID: 23770747
    [Abstract] [Full Text] [Related]

  • 12. [Dabigatran in the prevention of stroke in nonvalvular atrial fibrillation: complex clinical situations and real clinical practice].
    Tkacheva ON, Akasheva DU.
    Ter Arkh; 2014 Jul 16; 86(4):103-7. PubMed ID: 24864477
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic and clinical implications of dabigatran use in severe renal impairment for stroke prevention in nonvalvular atrial fibrillation.
    Mack DR, Kim JJ.
    Ann Pharmacother; 2012 Jul 16; 46(7-8):1105-10. PubMed ID: 22764329
    [Abstract] [Full Text] [Related]

  • 14. Potential inaccuracy of point-of-care INR in dabigatran-treated patients.
    Baruch L, Sherman O.
    Ann Pharmacother; 2011 Jul 16; 45(7-8):e40. PubMed ID: 21712509
    [Abstract] [Full Text] [Related]

  • 15. Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.
    Uchiyama S, Ibayashi S, Matsumoto M, Nagao T, Nagata K, Nakagawara J, Tanahashi N, Tanaka K, Toyoda K, Yasaka M.
    J Stroke Cerebrovasc Dis; 2012 Apr 16; 21(3):165-73. PubMed ID: 22440950
    [Abstract] [Full Text] [Related]

  • 16. New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatran.
    Barrios V, Escobar C.
    Expert Opin Pharmacother; 2012 Dec 16; 13(18):2649-61. PubMed ID: 23167273
    [Abstract] [Full Text] [Related]

  • 17. Dabigatran for stroke prevention in atrial fibrillation.
    Hohnloser SH, Diener HC.
    Hamostaseologie; 2012 Dec 16; 32(3):216-20. PubMed ID: 22739760
    [Abstract] [Full Text] [Related]

  • 18. [Dabigatran, a new oral anticoagulant].
    Uchiyama S.
    Brain Nerve; 2011 Apr 16; 63(4):411-5. PubMed ID: 21441645
    [Abstract] [Full Text] [Related]

  • 19. Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.
    Bendel SD, Bona R, Baker WL.
    Adv Ther; 2011 Jun 16; 28(6):460-72. PubMed ID: 21533567
    [Abstract] [Full Text] [Related]

  • 20. Advances in anticoagulation: focus on dabigatran, an oral direct thrombin inhibitor.
    Augoustides JG.
    J Cardiothorac Vasc Anesth; 2011 Dec 16; 25(6):1208-12. PubMed ID: 21982327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.